T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.62% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 15.29% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Annovis Bio
ANVS
$76.1M
| $257K | ﹤0.01% |
+3,000
| New | +$139K |
|
2627
BCE
BCE
$21.6B
| $257K | ﹤0.01% |
5,204
| – | – |
|
2628
IDT Corp
IDT
$1.65B
| $256K | ﹤0.01% |
+6,930
| New | +$197K |
|
|
CATC
2629
DELISTED
CAMBRIDGE BANCORP
CATC
| $256K | ﹤0.01% |
3,079
+701
| +29% | +$59.8K |
|
|
ARCH
2630
DELISTED
Arch Resources, Inc.
ARCH
| $256K | ﹤0.01% |
+4,501
| New | +$235K |
|
2631
State Street Technology Select Sector SPDR ETF
XLK
$125B
| $251K | ﹤0.01% |
3,400
| – | – |
|
|
PING
2632
DELISTED
Ping Identity Holding Corp.
PING
| $251K | ﹤0.01% |
10,946
+1,037
| +10% | +$24.4K |
|
|
AIM
2633
AIM ImmunoTech
AIM
$7.16M
| $251K | ﹤0.01% |
1,169
| – | – |
|
|
NAGE
2634
Niagen Bioscience
NAGE
$239M
| $250K | ﹤0.01% |
25,391
+7,113
| +39% | +$62K |
|
2635
GoodRx Holdings
GDRX
$1.23B
| $248K | ﹤0.01% |
6,900
-600
| -8% | -$22.1K |
|
2636
Children's Place
PLCE
$53.8M
| $248K | ﹤0.01% |
+2,662
| New | +$226K |
|
2637
VirnetX Holding Corp
VHC
$67.6M
| $248K | ﹤0.01% |
2,907
+577
| +25% | +$54.2K |
|
2638
Axogen
AXGN
$2.58B
| $247K | ﹤0.01% |
11,425
+825
| +8% | +$16.7K |
|
2639
Rigel Pharmaceuticals
RIGL
$763M
| $247K | ﹤0.01% |
5,685
+1,290
| +29% | +$48.7K |
|
|
SLCA
2640
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $247K | ﹤0.01% |
21,338
-2,922
| -12% | -$33.9K |
|
|
AGEN
2641
Agenus
AGEN
$307M
| $245K | ﹤0.01% |
2,277
+327
| +17% | +$24.5K |
|
2642
Western New England Bancorp
WNEB
$281M
| $245K | ﹤0.01% |
30,100
+4,456
| +17% | +$36.8K |
|
|
CAI
2643
DELISTED
CAI International, Inc.
CAI
| $245K | ﹤0.01% |
+4,377
| New | +$194K |
|
2644
Rockwell Medical
RMTI
$28.9M
| $242K | ﹤0.01% |
2,417
-464
| -16% | -$47.9K |
|
2645
Universal Technical Institute
UTI
$1.45B
| $242K | ﹤0.01% |
37,300
-2,198
| -6% | -$13K |
|
2646
Clarus
CLAR
$144M
| $241K | ﹤0.01% |
+9,395
| New | +$200K |
|
2647
Mercer International
MERC
$33.9M
| $241K | ﹤0.01% |
18,925
-82
| -0.4% | -$1.22K |
|
2648
MVB Financial
MVBF
$395M
| $241K | ﹤0.01% |
+5,650
| New | +$231K |
|
2649
Olema Pharmaceuticals
OLMA
$916M
| $241K | ﹤0.01% |
8,623
+173
| +2% | +$4.92K |
|
2650
Geron
GERN
$994M
| $239K | ﹤0.01% |
169,730
+3,555
| +2% | +$5.17K |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.